Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Cardiovascular Stroke

4-butyrolactone has been researched along with Cardiovascular Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, X; Ji, S; Li, M; Li, X; Liu, X1
Arts, IC; Boer, JM; Bueno-de-Mesquita, HB; Hollman, PC; Kok, FJ; Kuijsten, A; van't Veer, P1

Other Studies

2 other study(ies) available for 4-butyrolactone and Cardiovascular Stroke

ArticleYear
Screening of Bioactive Ingredients in Ligusticum Chuanxiong Hort for Protection against Myocardial Ischemia.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:3-4

    Topics: 4-Butyrolactone; Animals; Cardiotonic Agents; Chromatography, High Pressure Liquid; Coumaric Acids; Disease Models, Animal; Dogs; Ligusticum; Myocardial Infarction; Myocardial Ischemia; Plant Extracts; Reference Standards; Rhizome

2016
Plasma enterolignans are not associated with nonfatal myocardial infarction risk.
    Atherosclerosis, 2009, Volume: 203, Issue:1

    Topics: 4-Butyrolactone; Adult; Antioxidants; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Lignans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk; Treatment Outcome

2009